, Volume 100, Issue 3, pp 355–360 | Cite as

Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats

  • R. A. Wise
  • A. Murray
  • M. A. Bozarth
Original Investigations


Rats were trained to lever press for intravenous cocaine (1.0 mg/kg/injection) and then switched to bromocriptine (0.3, 1.0, or 3.0 mg/kg/injection) on a FR-1 reinforcement schedule. Bromocriptine sustained responding at all three doses; hourly drug intake increased linearly with log-dose. In a second experiment, animals were trained to respond for cocaine (1.0 mg/kg/injection) or heroin (0.1 mg/kg/injection) reinforcement; drug was available for the first 2 h of each daily session; saline was substituted for cocaine or heroin for 5 subsequent hours. One hour into each saline substitution session, an intravenous injection of saline or bromocriptine (0.0, 0.5, 1.0, or 2.0 mg/kg) was given. Bromocriptine reinstated both cocaine-trained and herointrained lever pressing; under these conditions, the drug was most effective in the heroin-trained animals. Reinforcing doses of clonidine (0.0625 and 0.125 mg/kg), methohexital, and nicotine (0.05 and 0.1 mg/kg), and a sub-intoxicating dose of ethanol (2 g/kg) failed to reinstate cocaine-trained responding. These data indicate that bromocriptine has cocaine-like and heroin-like stimulus and reinforcing effects.

Key words

Bromocriptine Cocaine Heroin Self-administration Reinforcement Reinstatement 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Acguas E, Carboni E, Leone P, Di Chiara G (1989) SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology 99:151–155Google Scholar
  2. Brown ZW, Amit Z, Weeks JR (1976) Simple flow-thru swivel for infusions into unrestrained animals. Pharmacol Biochem Behav 5:363–365Google Scholar
  3. Clarke PBS, Kumar R (1983) The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 78:329–337Google Scholar
  4. Collins RJ, Weeks JR, Cooper MM, Good PI, Russell RR (1984) Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology 82:6–13Google Scholar
  5. Dackis CA, Gold MS (1985a) Bromocriptine as treatment of cocaine abuse. Lancet I:1151–1152Google Scholar
  6. Dackis CA, Gold MS (1985b) New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 9:469–477Google Scholar
  7. Davis WM, Smith SG (1975) Effect of haloperidol on (+)-amphetamine self-administration. J Pharm Pharmacol 27:540–542Google Scholar
  8. Davis WM, Smith SG (1977) Catecholaminergic mechanisms of reinforcement: direct assessment by drug self-administration. Life Sci 20:483–492Google Scholar
  9. de Wit H, Stewart J (1981) Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 75:134–143Google Scholar
  10. de Wit H, Stewart J (1983) Drug reinstatement of heroin-reinforced responding in the rat. Psychopharmacology 79:29–31Google Scholar
  11. de Wit H, Wise RA (1977) Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol 31:195–203Google Scholar
  12. Di Chiara G, Imperato A (1988) Drugs of abuse preferentially stimulate dopamine release in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274–5278Google Scholar
  13. Di Mascio A, Havens LL, Klerman GL (1963) The psychopharmacology of phenothiazine compounds: a comparative study of the effects of chlorpromazine, promethazine, trifluoperazine, and perphenazine in normal males. 2. Results and discussion. J Nerv Ment Dis 136:168–186Google Scholar
  14. Dougherty J, Miller D, Todd G, Kostenbauder HB (1981) Reinforcing and other behavioral effects of nicotine. Neurosci Biobehav Rev 5:487–495Google Scholar
  15. Ettenberg A, Pettit HO, Bloom FE, Koob GF (1982) Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78:204–209Google Scholar
  16. Fibiger HC (1978) Drugs and reinforcement mechanisms: a critical review of the catecholamine theory. Ann Rev Pharmacol Toxicol 18:37–56Google Scholar
  17. Gerber GJ, Stretch R (1975) Drug-induced reinstatement of extinguished self-administration behavior in monkeys. Pharmacol Biochem Behav 3:1055–1061Google Scholar
  18. Gerhardt GA, Pang K, Rose GM (1987) In vivo electrochemical demonstration of the presynaptic actions of phencyclidine in rat caudate nucleus. J Pharmacol Exp Ther 241:714–721Google Scholar
  19. Griffiths RR, Brady JV, Bradford LD (1979) Predicting the abuse liability of drugs with animal drug self-administration procedures: psychomotor stimulants and hallucinogens. In: Thompson T, Dews PB (eds) Advances in behavioral pharmacology. Academic Press, New York, pp 163–208Google Scholar
  20. Heikkila RE, Orlansky H, Cohen G (1975) Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. Biochem Pharmacol 24:847–852Google Scholar
  21. Jaffe JH, Cascella NG, Kumor KM, Sherer MA (1989) Cocaine-induced cocaine craving. Psychopharmacology 97:59–64Google Scholar
  22. Markstein R (1981) Neurochemical effects of some ergot derivatives: a basis for their antiparkinson effects. J Neural Transm 51:39–59Google Scholar
  23. Matthews RT, German DC (1984) Electrophysiological evidence for excitation of rat ventral tegmental area dopaminergic neurons by morphine. Neuroscience 11:617–626Google Scholar
  24. Numan R (1981) Multiple exposures to ethanol facilitate intravenous self-administration of ethanol by rats. Pharmacol Biochem Behav 15:101–108Google Scholar
  25. Ostrowski NL, Hatfield CB, Caggiula AR (1982) The effects of low doses of morphine on the activity of dopamine containing cells and on behavior. Life Sci 31:2347–2350Google Scholar
  26. Pickens R, Thompson T (1968) Cocaine-reinforced behavior in rats: Effects of reinforcement magnitude and fixed-ratio size. J Pharmacol Exp Ther 161:122–129Google Scholar
  27. Pickens R, Muchow D, DeNoble V (1981) Methohexital-reinforced responding in rats: Effects of fixed ratio size and injection dose. J Pharmacol Exp Ther 216:205–209Google Scholar
  28. Risner ME, Jones BE (1980) Intravenous self-administration of cocaine and norcocaine by dogs. Psychopharmacology 71:83–89Google Scholar
  29. Roberts DCS, Corcoran ME, Fibiger HC (1977) On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 6:615–620Google Scholar
  30. Roberts DCS, Koob GF, Klonoff P, Fibiger HC (1980) Extinction and recovery of cocaine self-administration following 6-OHDA lesions of the nucleus accumbens. Pharmacol Biochem Behav 12:781–787Google Scholar
  31. Stewart J (1983) Conditioned and unconditioned drug effects in relapse to opiate and stimulant drug self-administration. Progress in Neuropsychopharmacol Biol Psychiatr 7:591–597Google Scholar
  32. Stewart J (1984) Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol Biochem Behav 20:917–923Google Scholar
  33. Wise RA (1978) Catecholamine theories of reward: a critical review. Brain Res 152:215–247Google Scholar
  34. Wise RA (1982) Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 5:39–87Google Scholar
  35. Wise RA (1987) The role of reward pathways in the development of drug dependence. Pharmacol Ther 35:227–263Google Scholar
  36. Wise RA (1988) The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol 97:118–132Google Scholar
  37. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469–492Google Scholar
  38. Wise RA, Rompré P-P (1989) Brain dopamine and reward. Annu Rev Psychol 40:191–225Google Scholar
  39. Wise RA, Yokel RA, de Wit H (1976) Both positive reinforcement and conditioned taste aversion from amphetamine and from apomorphine in rats. Science 191:1273–1274Google Scholar
  40. Woolverton WL, Goldberg LI, Ginos J (1984) Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 230:678–683Google Scholar
  41. Yokel RA, Pickens R (1974) Drug level ofd- andl-amphetamine during intravenous self-administration. Psychopharmacologia 43:255–264Google Scholar
  42. Yokel RA, Pickens R (1976) Extinction responding following amphetamine self-administration: determination of reinforcement magnitude. Physiol Psychol 4:39–42Google Scholar
  43. Yokel RA, Wise RA (1975) Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science 187:547–549Google Scholar
  44. Yokel RA, Wise RA (1976) Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology 48:311–318Google Scholar
  45. Yokel RA, Wise RA (1978) Amphetamine-type reinforcement by dopamine agonists in the rat. Psychopharmacology 58:289–296Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • R. A. Wise
    • 1
  • A. Murray
    • 1
  • M. A. Bozarth
    • 2
  1. 1.Center for Studies in Behavioral Neurobiology, Department of PsychologyConcordia UniversityMontrealCanada
  2. 2.Department of PsychologyState University of New YorkBuffaloUSA

Personalised recommendations